1. Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer

   • Nobukazu Tanaka
   • Tomohiro Enokida
   • Makoto Tahara

   Original Article 09 August 2022 Pages: 1669 - 1674

   

2. Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2)

   • Yosuke Ota
   • Takeshi Kodaira
   • Tetsuo Akimoto

   Original Article 24 August 2022 Pages: 1675 - 1683

   

3. miR-339-3p inhibits cell growth and epithelial–mesenchymal transition in nasopharyngeal carcinoma by modulating the KAT6A/TRIM24 axis

   • Pei Gao
   • Kun Zhao
   • Peng Zhang

   Original Article 17 August 2022 Pages: 1684 - 1697

   

4. Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy

   • Shoko Isoyama
   • Kakuhiro Yamaguchi
   • Noboru Hattori

   Original Article 03 September 2022 Pages: 1698 - 1705

   

5. The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery

   • Kumiko Sekiguchi
   • Akihisa Matsuda
   • Hiroshi Yoshida

   Original Article 11 August 2022 Pages: 1706 - 1716

   

6. Long-term outcomes of D2 vs. D3 lymph node dissection for cT2N0M0 colorectal cancer: a multi‑institutional retrospective analysis

   • Tadahiro Kojima
   • Hitoshi Hino
   • Kenichi Sugihara

   Original Article 27 August 2022 Pages: 1717 - 1724

   

7. Clinical effectiveness of surgical treatment after lenvatinib administration for hepatocellular carcinoma

   • Shinji Itoh
   • Katsuya Toshida
   • Tomoharu Yoshizumi

   Original Article 12 August 2022 Pages: 1725 - 1732

   

8. First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer

   • Nobutaka Nishimura
   • Makito Miyake
   • Kiyohide Fujimoto

   Original Article 27 August 2022 Pages: 1733 - 1741

   

9. Human papillomavirus testing and cytology using physician-collected uterine cervical samples vs. self-collected vaginal samples and urine samples

   • Noriko Terada
   • Motoki Matsuura
   • Tsuyoshi Saito

   Original Article 11 September 2022 Pages: 1742 - 1749

10. The ‘best friend effect’: a promising tool to encourage HPV vaccination in Japan

    • Asami Yagi
    • Yutaka Ueda
    • Tadashi Kimura

    Original Article 03 September 2022 Pages: 1750 - 1757

11. Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study

    • Toshihide Hirai
    • Hiroshi Kobayashi
    • Sakae Tanaka

    Original Article 06 August 2022 Pages: 1758 - 1766

    

12. Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review

    • Ying Wang
    • Megan Delisle
    • Amirrtha Srikanthan

    Original Article 22 August 2022 Pages: 1767 - 1779

    

13. Usefulness of ultrasonography and elastography in diagnosing oxaliplatin-induced sinusoidal obstruction syndrome

    • Rika Saito
    • Yasuyuki Kawamoto
    • Naoya Sakamoto

    Original Article Open access 30 August 2022 Pages: 1780 - 1790

    

14. Letter to the Editor: Inflammation influences the prognosis of hepatocellular carcinoma

    • Xiao Liu
    • Shunda Du

    Letter to the Editor 12 August 2022 Pages: 1791 - 1792

15. Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)

    • Kenjiro Aogi
    • Kenichi Watanabe
    • Shinji Ohno

    Correction Open access 27 September 2022 Pages: 1793 - 1793